Microbix Biosystems Inc.
(MENAFN- Baystreet) 09:52 AM EST - Microbix Biosystems Inc.: Announces that it has commercialized custom biological materials for incorporation into the lab-based assays or point-of-care test-cartridges of in-vitro diagnostics manufacturers. Initial sales have been made to two DxMs, each of which is incorporating a Microbix biologic material into a new assay or assays. Microbix Biosystems Inc.
shares T are trading unchanged at $0.28.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment